“novo-holdings” Archives

in
Entry Author Date Location
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections 08/12/20 Europe
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug 02/20/20 San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Novo Holdings Repositions Antibiotics Funding Amid “Deteriorated” Market 01/07/20 Europe
Novo Ventures Commits $25M to Grow Discovery “Greenhouse” in Boston 11/19/19 Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Bolt Bio Bags $54M for Drugs that Turn the Heat Up on “Cold” Tumors 02/05/19 San Francisco
Kaleido Bio and Cirius Join an IPO Queue Stalled by Federal Shutdown 01/11/19 Boston
Aristea Therapeutics Raises $15M to Develop Anti-Inflammatory Drugs 12/20/18 San Diego
Morphic Nets Another $80M For Integrin Drugs & First Human Tests 09/25/18 Boston
Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More 03/02/18 National
Page 1 of 1